【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 7
1.2 List of Figures 10
2 Pharmaceuticals & Healthcare, Global, Deal Summary 13
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, June 2013 13
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, June 2013 15
2.2.1 Tenet Healthcare to Acquire Vanguard Health Systems for US$4.3 Billion 15
2.2.2 Baxter Completes Public Offering of Notes for $3.5 Billion 16
2.2.3 Thermo Fisher Announces Underwriters’ Exercise of Over-Allotment Option for Public Offering of Shares for US$2.53 Billion 16
2.2.4 Valeant Pharma Completes Public Offering of Shares for US$2.3 Billion 17
2.2.5 KKR to Acquire PRA International from Genstar Capital 18
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, June 2013 19
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, June 2013 20
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 21
3.1 Pharmaceuticals & Healthcare, Global, M&A, June 2013 21
3.1.1 Top M&A Deals in June 2013 22
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, January 2013 – June 2013 23
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, June 2013 25
3.2.1 Top Equity Offering Deals in June 2013 26
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, January 2013 – June 2013 27
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, June 2013 29
3.3.1 Top PE/VC Deals in June 2013 30
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, June 2013 31
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, June 2013 32
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, January 2013–June 2013 34
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, January 2013–June 2013 35
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, June 2013 36
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, June 2013 36
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, January 2013 – June 2013 38
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), June 2013 40
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, June 2013 41
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), January 2013 – June 2013 42
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, January 2013 – June 2013 44
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), January 2013 – June 2013 45
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), January 2013 – June 2013 46
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, June 2013 48
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, June 2013 48
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), June 2013 50
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, June 2013 51
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, June 2013 51
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, June 2013 52
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), January 2013 – June 2013 53
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), January 2013 – June 2013 55
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), January 2013 – June 2013 57
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), January 2013 – June 2013 59
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 61
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, June 2013 61
6.1.1 Oncology – Deals of the Month 63
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, June 2013 64
6.2.1 Central Nervous System – Deals of the Month 66
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, June 2013 67
6.3.1 Infectious Diseases – Deals of the Month 69
6.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, June 2013 70
6.4.1 Cardiovascular – Deal of the Month 71
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, June 2013 73
6.5.1 Metabolic Disorders – Deal of the Month 75
6.6 Pharmaceuticals & Healthcare, Global, Immunology Deals, June 2013 76
6.6.1 Immunology – Deal of the Month 77
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, June 2013 78
6.7.1 Gastrointestinal – Deal of the Month 79
7 Deal Summary by Geography 80
7.1 Pharmaceuticals & Healthcare, North America Deals, June 2013 80
7.1.1 North America – Deals of the Month 81
7.2 Pharmaceuticals & Healthcare, Europe, Deals, June 2013 83
7.2.1 Europe – Deals of the Month 84
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, June 2013 86
7.3.1 Asia-Pacific – Deals of the Month 88
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, June 2013 89
7.4.1 Rest of the World – Deals of the Month 90
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 92
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, January 2013 – June 2013 92
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, January 2013 – June 2013 94
9 Further Information 96
9.1 Methodology 96
9.2 About GlobalData 97
9.3 Disclosure information 98
9.4 Disclaimer 98
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：June 2013（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for June 2013 in Pharmaceuticals
■ 発行日：2013年7月31日
■ 調査会社：GlobalData
■ 商品コード：GDATA403161513
■ 調査対象地域：グローバル
- 金融サービス向けソフトウェアの世界市場：監査・リスク・コンプライアンス管理、BI・分析アプリケーション、取引処理、顧客経験管理Banking and Financial services form the backbone of any country’s economy. In recent times, the strength of country is determined by how it is progressing financially. Thus, proper functioning of financial system is must to bring in stable and smooth governance. Many banks and financial institutions around the globe have turned their attention to pull the customers by decisive marketing efforts an …
- 世界の高純度アルミナ市場動向（2014-2018）About High-purity Alumina Alumina, commonly known as aluminum oxide (Al2O3), is primarily used as a feedstock for the fabrication of metallic aluminum and is known as Smelter Grade Alumina (SGA). While 90 percent of the alumina produced globally is used in aluminum fabrication, the remaining 10 percent is dedicated to the non-metallurgical market, i.e., for industrial usage. High-purity alumina, w …
- 膜用化学品の世界市場：インサイト、市場機会、市場シェア、市場予測The global membrane chemical market is estimated to register robust growth in 2016- 2022 and is expected to grow at CAGR of 8.5% during 2016-2022. The Membrane chemical market is segmented on the basis of product, end user and geography. The end user segment is further segmented into Chemicals, Desalination, Food and Beverage, Paper & Pulp, Power, Waste water treatment. However, in the end user se …
- 半導体製造用ソフトウェアの世界市場2017-2021About Semiconductor Fabrication Software Semiconductor fabrication software comprises design software tools (EDA tools) and production software tools. Electronic design automation (EDA) is a software tool that is used to design electronic systems. It can vary for computer or mobile device chips to chips used in satellites. The value of EDA tools is increasing over time due to the growing complexit …
- Remicade (Psoriasis)：市場予測と分析（～2022）Remicade (Psoriasis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Remicade (Psoriasis) - Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Psoriasis (PsO), so this remains at the top of the list for unmet needs. While physicians agree that biologics are relatively safe and effective, these th …
- 美容整形外科の世界市場2016-2020About Cosmetic Surgery Cosmetic surgery is a procedure carried out to improve the appearance of specific parts of the body. Both men and women may opt for these surgeries, and they are usually carried out over areas which are otherwise functioning perfectly. Cosmetic surgery is elective in nature and falls outside the purview of medical reimbursements. Technavio’s analysts forecast the global cosm …
- ACドライブの世界市場予測（～2021年）：低電圧ACドライブ、中電圧ACドライブThe global AC drives market is projected to grow at a CAGR of 7.0% from 2016 to 2021, to reach a market size of USD 22.07 Billion by 2021. This growth is attributed to the increasing urbanization & industrialization, rising need for energy efficiency, and regulations on energy efficiency. The report segments the AC drives market based on end-user industries into oil & gas, water & wastewater, powe …
- Vectren Corporation：石油・ガスバリューチェーン分析レポート2013Vectren Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Vectren Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Vectren Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examine …
- ステープルPP（ポリプロピレン）不織布の世界市場分析：用途別（衛生、産業、医療、ジオテキスタイル、家具、カーペット、農業）、セグメント予測、-2020The global staples PP nonwoven fabric market is expected to reach USD 9.02 billion by 2020. Growing baby diapers and adult incontinence products demand is expected to drive global staples PP nonwoven fabric market over the next six years. Increasing staples PP nonwoven fabrics penetration in automotive and industrial applications is also expected to have a positive influence on the market growth. …
- 有機ライスタンパク質の世界市場分析：製品別（ライスタンパク質分離物、ライスタンパク質濃縮物）、用途別（スポーツ･エネルギー栄養学、製パン･製菓、肉類代用品･増量剤、乳製品代替品）、セグメント予測The global organic rice protein market is expected to reach USD 154.4 million by 2024, according to a new report by Grand View Research, Inc. Superior functional properties coupled with increasing shift towards non-GMO and vegan food ingredients is expected to propel the demand over the forecast period. The product is hypoallergenic and generally consists of no added colors, sweeteners or fillers …
- グローバルにおけるスマートグリッド市場動向：September 2014Smart Grid Review - September 2014 Summary A substantial number of smart grid developments took place in August 2014, including product launches, fundraising events and the announcement and completion of contracts and projects.Two major acquisitions took place in August, with Schneider Electric acquiring Günsan Elektrik, a key company offering wiring device accessories in Turkey. Another major acq …
- 暗視装置の世界市場：暗視カメラ、暗視スコープ、暗視ゴーグルThe global night vision device market was valued at USD 5.07 Billion in 2015, and is expected to grow at a CAGR of 8.8% from 2015 to 2020, to reach USD 7.73 Billion by 2020. The night vision devices are used in various applications such as surveillance, military, security, hunting, navigation, hidden object detection, paranormal research and others. The scope of this report covers the night vision …
- ノルマルブタノールの世界市場動向及び予測N-butanol (C4H9OH) or n-butyl alcohol or normal butanol is a clear colorless flammable liquid. It is readily biodegradable with low level of toxicity. N-butanol is used as a feedstock for manufacturing various chemicals including butyl acrylate, butyl acetate, glycol ethers, and plasticizers. It is also used as direct solvent for paints, coatings, varnishes, resins, dyes, camphor, vegetable oils, …
- B型肝炎ワクチンの世界市場機会分析Hepatitis B virus (HBV) is transmitted by exposure to infectious blood or body fluids by percutaneous or mucosal means. Transmission occurs usually amongst adults exhibiting risk behaviours e.g. IDUs, MSM and heterosexuals with multiple partners although vertical transmission can occur from mother to child at birth. The HBV virus is more infectious than HIV and can cause chronic infection, resulti …
- コネクテッド・ロジスティクスの世界市場予測（～2021年）“The evolution of connected vehicles and increasing logistics transparency across the globe and the increasing adoption of connected and intelligent devices are some of the factors expected to drive the connected logistics market” The connected logistics market size is estimated to grow from USD 10.04 billion in 2016 to USD 41.30 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 32.7%. T …
